| INTRODUCTION
The incidence of type 1 diabetes (T1D) in children younger than 14 years is increasing globally. 1 However, the contributing factors to this increase are poorly understood. [1] [2] [3] Large-scale studies such as the World Health Organization's (WHO) DiaMond study 4 and the EURODIAB ACE study 5 have collected standardized incidence data for T1D among children under 15 years of age in different populations and showed large regional differences. The highest incidence of T1D was found in northern Europe and the lowest in China. 6 Of particular concern is the doubling in incidence of T1D over the last generation in Europe and the shift to diagnosis at a younger age. 7, 8 The importance of good quality data, based on well-established diabetes registries, is critical to monitor trends in the incidence of T1D in children globally. Unfortunately, the cost of maintaining such registries is often prohibitive. For example, in Kuwait a registry, as part of the DiaMond project was used during 1992-1997 to collect data on childhood-onset T1D in children. On the basis of these data, the age standardized rate in Kuwaiti children was reported to be 20.9 per 100,000 per year. 9 The Kuwait registry was discontinued until †
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data collection was re-established by the introduction of the Childhood Onset Diabetes eRegistry (CODeR) in 2011. All children aged 0-14 years who were discharged from hospital after diagnosis of newly onset T1D based on IDF/ISPAD guidelines 13 and who met the following criteria were eligible for inclusion in the registry: (i) diagnosed with T1D; (ii) resident of Kuwait; (iii) treated with insulin from the time of diagnosis of diabetes which is not secondary to other conditions. 9 The date of onset was defined as the date of the first insulin injection. 14 Children discharged from hospital constituted the primary source to estimate the degree of ascertainment. 6 This study included only Kuwaiti children and analysis was restricted to those aged 0-14 years for comparison with other historical studies.
| Data capture and governance
Data used in this study were collected using CODeR, a national dis- with family history of type 2 diabetes (T2D) in first degree relatives, skin manifestations of insulin resistance, negative pancreatic autoantibodies, high insulin, and high C-peptide values were excluded from further data treatment. 12 The protocol included a systematic review of the patients' records, similar to the DiaMond standard protocol 6 to allow a detailed study of relevant records using the WHO International Classification of Disease (ICD) standards 15 using ICD-10.
Information on the total number of Kuwaiti children in the different age groups was obtained from the official statistics provided by the Public Authority of Civil Information for 2011 to 2013.
| Ascertainment: capture-recapture
The registry used the capture-recapture method to estimate the degree of ascertainment as recommended by the WHO DiaMond Project. 6 Ascertainment probability (percentage) described previously 16 was calculated using the equation
where a is the number of cases found by either source, b is the number found by the secondary source only and c is the number found by the primary source only.
| Statistical analysis
Age adjustment was done in 5 year intervals (0-4, 5-9, and 10-14 years) using the direct method with a standard population consisting of equal numbers of children in each of 3 subgroups. 6 Age-specific incidence rates were calculated for the different age groups for each year of the study. Poisson regression was used to derive ratios between the incidence rates during 1992-1994 versus 1995-1997 and also between the incidence rates during 1992-1994 versus 2011-2013. Annual rate of increase in incidence rates was calculated based on the incidence of T1D in children 0-14 years from 1992-1997 9 to 2011-2013 using Poisson regression. Data analysis was performed using the computing environment of R. Non-Kuwaiti children (n = 206; 28.6%) were excluded from analysis.
Out of 515 Kuwaiti children, 247 were boys and 268 were girls; the male to female ratio was 0.9. The mean age AE SD at diagnosis was 8.7 AE 3.4 years for boys and 7.9 AE 3.1 years for girls. When patients were classified into age groups, 103 (20.0%), 225 (43.7%), and 187 (36.3%) of the children were in the age groups 0-4, 5-9, and 10-14 years respectively. Two infants aged 9 and 11 months are included in the data set as the youngest children diagnosed with T1D. The crude incidence rate (95% CI) in 2011-2013 was 40.9
(37.4-44.6) and the age standardized rate was 41.7 (95% CI. 38.1-45.4) per 100,000 per year. The gender-specific incidence rate among boys was 38.4 (95% CI 33.7-43.4) and girls 43.5 (95% CI 38.5-49.1)
per 100,000 per year ( Table 1 ). The youngest age group (0-4 years)
had significantly lower incidence rate as compared with the 2 older age groups (P < .001). The difference in the incidence rate between children 5-9 and 10-14 years was only statistically significantly different in 2013 (P < .05).
| Comparison with previous registry
Results were compared to data collected from 1992 to 1997. In these datasets, the degree of case ascertainment varied between 90% and 96% with an average of 92.5%. 9 In the previous dataset, the age standardized rate was 20.9 (95% CI 18.8-23.0) and in 2011-2013 it was 41.7
(95% CI 38.1-45.4), indicating a doubling of the incidence rate of T1D during the last 2 decades (1992 to 2013). The age-specific incidence (Table 2) 1% for all age groups, and 3.2%, 4.9% ,and 3.3% for the age groups 0-4, 5-9, and 10-14 years respectively (Table 2) . No statistically significant difference in incidence of T1D was found between boys and girls in any dataset.
| DISCUSSION
Kuwait was previously reported to have the fourth highest incidence of T1D in the world. 7 Based on the recent nationwide registry, implemented according to the DiaMond protocol, a twofold increase in incidence rate is seen during the last 20 years in Kuwaiti native children, as the incidence of T1D increased from 17.7 per 100,000 per year (1992 to 1994) to 40.9 per 100,000 per year (2011 to 2013).
Our data thus support the observation of a North to South gradient in T1D incidence, with the exception of 2 'hot spots', that is, Sardinia and Kuwait, 4 where T1D incidence is approaching the situation in Finland in the nineties. 18 However, Kuwait does not represent an isolated case of increasing incidence in the Gulf region, as high incidence rates of T1D have been reported from neighboring countries. 19, 20 In particular, data from the Eastern province of Saudi Arabia has shown an increased incidence of T1D from 18.1 per 100,000 to 36.9 per 100,000 per year between 1990 and 2007. , showing a trend similar to that observed in Kuwait. Clearly, our data contribute to the overall conclusion that the global trend of incidence of T1D is still on the rise across the world [22] [23] [24] with a few exceptions such as a recent study from the Biscay region of Spain. 25 Among Kuwaiti children, we found an overall annual increase in T1D incidence of 4.1%, over the last 2 decades. These results are well in agreement with international data, as an average relative increase of 3-4% per calendar year has been reported worldwide. 7 Although we did not find any statistically significant differences between boys and girls, the annual increase was slightly higher in girls aged 5-9 years (5.4%). In contrast to the previously reported observation that T1D incidence is increasing in younger children 26 our data show that the youngest age group (0-4 years) had statistically significant lower incidence rates as compared with older children (P < .001). This observation is in agreement with pooled data from the DiaMond study, showing that 5 to 9-year-old children had a 1.62 times higher risk of developing T1D compared with 0 to 4-year-old children. 4 In addition, only minor differences were found between children aged 5-9 and 10-14 years as the incidence rates were only statistically different in 1 year (2013) between these age groups. We did not observe any significant gender differences, although, in general, high incidence countries tend to have a slight male excess, while the opposite is seen in low incidence countries 4 with a few exceptions. 19, 20, 27 The reasons for the increasing incidence of T1D globally are largely unknown in spite of numerous large-scale studies implemen- In addition, although there is long-term experience in the diagnosis of diabetes globally, it is important to stress that accurate diagnosis of different types of diabetes remains difficult and controversial. 35 It has been suggested that a scheme of islet autoantibody testing, with the aid of HLA-DR, DQ genotyping, and fasting C-peptide measurement in autoantibody-negative subjects may be necessary for correct diagnosis of diabetes. 7, 35 Currently, diagnosis of diabetes does not include such elaborate testing and, for example, in our dataset it cannot be ruled out that some children with T2D have been misdiagnosed as T1D. However, based on the strict inclusion/exclusion criteria used for the registry, we are confident that the misclassification of children was kept to a minimum. For any comparison with previous data, such as in our study, the influence of changes to medical practice and/or procedures (for example the coding systems) cannot be ruled out but is assumed to not influence the data significantly.
A further limitation to our study is that the duration of the registry was relatively short. It would be important to expand the registry to continue monitoring incidence of T1D and evaluate trends in a high incidence country such as Kuwait. The need for long-term health care of children diagnosed with T1D cannot be underestimated and with increasing numbers of children diagnosed, additional resources must be made available to provide state-of-the-art care.
Our data clearly indicate the importance of well-established electronic registries to monitor trends in incidence of T1D in the pediatric population. In Kuwait, the use of a unique identification number facilitated the quality control of data. Furthermore, close collaboration of researchers and clinicians working in a small country made the implementation of a nationwide registry feasible but also highlighted the importance of securing adequate resources to continue data collection. 
